Published in Ann Intern Med on October 01, 1970
An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest (1972) 2.61
Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med (1974) 1.74
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med (1993) 1.45
The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest (1993) 1.38
Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest (1984) 1.35
Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest (1983) 1.32
Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesota. Infect Immun (1977) 1.32
Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest (1983) 1.22
Proteolytic inactivation of plasma C1- inhibitor in sepsis. J Clin Invest (1989) 1.22
Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf. J Clin Invest (1986) 1.05
Activation of the contact system in lethal hypotensive bacteremia in a baboon model. Am J Pathol (1992) 0.95
Are hemostasis and thrombosis two sides of the same coin? J Exp Med (2006) 0.95
Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1. Br J Pharmacol (1991) 0.95
Plasma kallikrein activation and inhibition during typhoid fever. J Clin Invest (1978) 0.94
Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor. J Clin Invest (1993) 0.93
Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment. J Clin Invest (1986) 0.91
Coagulation changes of septic shock in the sub-human primate and their relationship to hemodynamic changes. Ann Surg (1972) 0.85
A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis. Am J Pathol (2004) 0.82
Toxicity of group B Streptococcus agalactiae in adult rats. Infect Immun (1985) 0.80
Recombinant alpha 1-antitrypsin Pittsburgh attenuates experimental gram-negative septicemia. Am J Pathol (1988) 0.79
Potentiation of endotoxin-induced consumptive coagulopathy by lead acetate administration. Infect Immun (1974) 0.78
Turnover of human and monkey plasma kininogens in rhesus monkeys. J Clin Invest (1979) 0.75
The plasma kallikrein kinin system in severely ill and traumatised patients. Arch Emerg Med (1984) 0.75
A model for the interplay of inflammatory mediators in sepsis--a study in 48 patients. Intensive Care Med (1990) 0.75
Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ (1998) 8.27
Acrasin, Acrasinase, and the sensitivity to acrasin in Dictyostelium discoideum. Dev Biol (1969) 3.56
Mechanical initiation of intervertebral disc degeneration. Spine (Phila Pa 1976) (2000) 2.76
Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep (1978) 2.63
'Stress' distributions inside intervertebral discs. The effects of age and degeneration. J Bone Joint Surg Br (1996) 2.39
Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry (1995) 2.39
Effect of heparin on the activation of factor XII and the contact system in plasma. Thromb Haemost (1991) 2.29
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation (1983) 2.24
Platelet function in hyperlipoproteinemia. N Engl J Med (1974) 2.23
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation. Dig Liver Dis (2005) 2.18
Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med (1983) 2.18
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol (1980) 2.17
Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 2.11
Interaction of plasma kallikrein with the C1 inhibitor. J Immunol (1970) 2.07
Amiodarone. N Engl J Med (1987) 2.05
Advances in the understanding of myocarditis. Circulation (2001) 1.93
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest (1975) 1.88
Disseminated intravascular coagulation (DIC): an approach. Am J Med (1972) 1.87
Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation (1996) 1.86
Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation (1997) 1.84
Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med (1983) 1.81
Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry (1993) 1.81
Health state valuations from the general public using the visual analogue scale. Qual Life Res (1996) 1.71
Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A (1976) 1.69
Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep (1978) 1.68
Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol (1978) 1.68
A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosom Med (1969) 1.65
Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med (1992) 1.65
Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis (1990) 1.63
Early anthracycline cardiotoxicity. Am J Med (1978) 1.63
Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62
Purification and characterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from Porphyromonas gingivalis that cleaves kininogens and fibrinogen. J Biol Chem (1993) 1.61
Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry (1993) 1.56
Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest (1975) 1.55
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest (1969) 1.52
Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry (1991) 1.52
Principles of justice in health care rationing. J Med Ethics (2000) 1.50
Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring. Circulation (1997) 1.49
Personal risk factors for first-time low back pain. Spine (Phila Pa 1976) (1999) 1.48
Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis (1998) 1.48
Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest (1982) 1.45
The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med (1969) 1.45
Valuing health status using VAS and TTO: what lies behind the numbers? Soc Sci Med (1997) 1.45
Public views on health care rationing: a group discussion study. Health Policy (1999) 1.44
Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun (1969) 1.44
Asymmetric low back loading in asymmetric lifting movements is not prevented by pelvic twist. J Biomech (1998) 1.44
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest (1977) 1.42
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters. Blood (1998) 1.42
Multiple hormonal responses to graded exercise in relation to physical training. J Appl Physiol (1972) 1.42
Good outcome from surgery for ampullary tumour. Aust N Z J Surg (1999) 1.41
Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen. Biochemistry (1981) 1.41
Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor. J Clin Invest (1984) 1.40
Invited letter concerning: aprotinin. J Thorac Cardiovasc Surg (1991) 1.40
Inhibition of insulin secretion by infused epinephrine in rhesus monkeys. Endocrinology (1966) 1.39
Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood (1986) 1.38
The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest (1993) 1.38
Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest (1984) 1.35
Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis (1986) 1.35
Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med (1978) 1.34
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein. J Clin Invest (1969) 1.34
Biochemical effects of dithiolthiones. Food Chem Toxicol (1986) 1.33
More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters. Transfusion (1996) 1.33
Effects of Physicochemical Factors and Bacterial Colony Morphotype on Association of Vibrio vulnificus with Hemocytes of Crassostrea virginica. Appl Environ Microbiol (1993) 1.32
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation (1978) 1.28
Malignant ventricular tachyarrhythmias associated with the use of encainide. Am Heart J (1981) 1.27
Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis (1985) 1.27
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry (1984) 1.25
Multiple hormonal responses to prolonged exercise in relation to physical training. J Appl Physiol (1972) 1.24
Pulse oximetry: evaluation of accuracy during outpatient general anesthesia for oral surgery. Anesth Prog (1988) 1.23
Viability of Vibrio vulnificus in Association with Hemocytes of the American Oyster (Crassostrea virginica). Appl Environ Microbiol (1995) 1.23
Origin of the high molecular weight activator of prekallikrein. J Biol Chem (1973) 1.22
Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest (1983) 1.22
Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest (1982) 1.21
Formation of human plasma kinin. N Engl J Med (1974) 1.21
Serum-free and protein-bound sugars and cardiovascular complications in diabetes mellitus. Lab Invest (1976) 1.19
3'5' AMP and Ca 2+ in slime mold aggregation. Exp Cell Res (1971) 1.18
Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry (1993) 1.18
Human plasma prekallikrein: a rapid high-yield method for purification. Eur J Biochem (1979) 1.17
Recent advances in lumbar spinal mechanics and their clinical significance. Clin Biomech (Bristol, Avon) (1995) 1.17
1,2-Dithiol-3-thione analogs: effects on NAD(P)H:quinone reductase and glutathione levels in murine hepatoma cells. Carcinogenesis (1986) 1.17
The regulation of human factor XIIa by plasma proteinase inhibitors. J Biol Chem (1985) 1.17
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb (1992) 1.16
Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest (1975) 1.16
Diurnal changes in spinal mechanics and their clinical significance. J Bone Joint Surg Br (1990) 1.16
Sustained loading generates stress concentrations in lumbar intervertebral discs. Spine (Phila Pa 1976) (1996) 1.15
Vertebral fractures usually affect the cranial endplate because it is thinner and supported by less-dense trabecular bone. Bone (2008) 1.14
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N Engl J Med (1970) 1.14
Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res (1984) 1.14
Diurnal variations in the stresses on the lumbar spine. Spine (Phila Pa 1976) (1987) 1.13
Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest (1982) 1.13
Endomyocardial biopsy: the balance of success and failure. Circulation (1985) 1.13
The effect of past and present illness experience on the valuations of health states. Med Care (1995) 1.12
Identification of adenine nucleotide binding proteins in human platelet membranes by affinity labeling with 5'-p-flurosulfonylbenzoyl adenosine. J Biol Chem (1978) 1.11